Seres Therapeutics
MCRB
#9469
Rank
โ‚น7.92 B
Marketcap
โ‚น826.28
Share price
-0.11%
Change (1 day)
-28.65%
Change (1 year)

EPS for Seres Therapeutics (MCRB)

EPS in 2025 (TTM): โ‚น1,185

According to Seres Therapeutics's latest financial reports the company's current EPS (TTM) is โ‚น1,311. In 2024 the company made an earnings per share (EPS) of N/A an increase over its 2023 EPS that were of -โ‚น1,660.

EPS history for Seres Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น1,185
2024N/A-100%
2023-โ‚น1,660-61.47%
2022-โ‚น4,309220.83%
2021-โ‚น1,343-35.71%
2020-โ‚น2,089-9.68%
2019-โ‚น2,313-48.97%
2018-โ‚น4,5329.95%
2017-โ‚น4,122-3.91%
2016-โ‚น4,290-1.29%
2015-โ‚น4,346285.48%
2014-โ‚น1,127157.99%
2013-โ‚น436.9942.44%
2012-โ‚น306.79

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Xencor
XNCR
-โ‚น165.07-112.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Agios Pharmaceuticals
AGIO
โ‚น1,062-18.99%๐Ÿ‡บ๐Ÿ‡ธ USA